Associate Scientist, Cancer Immunology Discovery at Bristol-Myers Squibb

Winter Garden, Florida, United States

Apply Now

Not SpecifiedCompensation

Junior (1 to 2 years), Mid-level (3 to 4 years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, Pharmaceuticals, OncologyIndustries

Requirements

Bachelor’s Degree
2+ years of academic and/or industry experience
Scientific knowledge in immunology or cancer biology (preferred)
Experience with mammalian cell culture (e.g., T cells, stromal cells, stem cells) and cancer cell line culture (preferred)
Experience with expression modulation tools (e.g., overexpression, CRISPRs, RNAi, etc.) and generation of stable cell lines (preferred)
Experience in immunology or cell biology techniques (e.g., immune cell isolation and expansion, flow cytometry, immuno-fluorescence imaging, live cell imaging, cytokine ELISA, etc.) (preferred)
Ability to summarize and interpret scientific data in a clear, concise, and accurate manner (preferred)
Familiar with biologics therapeutics (e.g., monoclonal antibodies, bispecific antibodies, etc.) (preferred)
Understand basics to use generative AI to accelerate workflow (preferred)

Responsibilities

Work with a robust team to support program advancement in the cancer immunology space
Execute in vitro experiments related but not limited to tissue culture, multi-parametric flow cytometry, western blot, immune cell culture, proliferation and tumor cell killing assays, 2D/3D co-culture activity assays, ELISA, Luminex, processing of DNA/RNA/protein
Analyze, interpret and present experimental data to internal and external audiences
Participate in problem troubleshooting and initiatives related to continuous improvement or development of new approaches/technologies
Accurate and detailed record-keeping
Communicate and collaborate with scientists from other functional areas

Skills

Cancer Biology

Immuno-oncology

In Vitro Models

In Vivo Models

Ex-Vivo Models

Drug Discovery

Target Identification

Target Validation

Biomarker Development

Translational Medicine

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free